π’The Phase 1/2a HEADLINE Trial of ABS-201, an AI-designed antibody for Androgenetic Alopecia (commonly known as female/male pattern hair loss) is now enrolling participants.
@bigpey It should still be on your system some place. Contact Cardano foundation direct. If you send a public message on official discord or official telegram then wait for a public reply on the group. ( No DM)